Pacific Biosciences of California, Inc. (FRA:P09)

Market Cap	404.77M +12.5%
Revenue (ttm)	136.28M +3.9%
Net Income	-465.35M
EPS	-1.55
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	2,405
Open	1.320
Previous Close	1.403
Day's Range	1.320 - 1.320
52-Week Range	0.780 - 2.300
Beta	n/a
RSI	57.77
Earnings Date	May 7, 2026

About FRA:P09

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified...

• Industry: Laboratory Analytical Instruments
• Founded: 2000
• Employees: 485
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: P09

Financial Performance

In 2025, FRA:P09's revenue was $160.01 million, an increase of 3.89% compared to the previous year's $154.01 million. Losses were -$546.38 million, 76.3% more than in 2024.

Financial numbers in USD